Business

Announcement on Voluntary Disclosure of the Thoracic Main Multibranch Stent Receiving Breakthrough Device Designation from the U.S. FDA

Announcement on Voluntary Disclosure of the Thoracic Main Multibranch Stent Receiving Breakthrough Device Designation from the U.S. FDA

articleShanghai Microport Endovascular Medtech Co., Ltd Class AMarch 1, 20263/news/announcement-on-voluntary-disclosure-of-the-thoracic-main-multibranch-stent-receiving-breakthrough-device-designation-from-the-us-fda
Announcement on Voluntary Disclosure of the Thoracic Main Multibranch Stent Receiving Breakthrough Device Designation from the U.S. FDA

About this update from Shanghai Microport Endovascular Medtech Co., Ltd Class A

Announcement on Voluntary Disclosure of the Thoracic Main Multibranch Stent Receiving Breakthrough Device Designation from the U.S. FDA The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shanghai Microport Endovascular Medtech Co., Ltd Class A